Hey HC,
This stock has popped up on my screener. I can see the upside, but am havimg trouble quantifying what the potential downsides are.
Have other countries been throgh this process of regulating margins on generic drugs? How do the prices / margins compare to selling drugs in australia etc? What caused those countries to change? Any reccomended resources?
Also, not sure i can ignore the ethics behind over charging for healthcare. Seems like they are taking advantage of vulnerable people (not that they are the only one).
Quantifying downside risks
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$7.11 |
Change
0.180(2.60%) |
Mkt cap ! $604.8M | |||
| Open | High | Low | Value | Volume |
| $6.97 | $7.17 | $6.97 | $799.6K | 112.4K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 32 | $7.10 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $7.12 | 331 | 1 |
View Market Depth
| Last trade - 16.10pm 29/04/2024 (20 minute delay) ? |
|
|||||
|
Last
$7.10 |
Change
0.180 ( 2.45 %) |
||||
| Open | High | Low | Volume | ||
| $6.97 | $7.18 | $6.97 | 24352 | ||
| Last updated 15.59pm 29/04/2024 ? | |||||
| MYX (ASX) Chart |